Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 6/20 | 0.36 |
| ▸ | RXRB | P28702 | 5/20 | 0.36 |
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | RXRG | P48443 | 5/20 | 0.34 |
| ▸ | XDH | P47989 | 2/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15779890 | 0.93 | CTSS (0.37) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL10072958 | 0.93 | CTSS (0.37) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL12149288 | 0.92 | RXRA (0.36) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL12149290 | 0.91 | RXRA (0.35) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL2755915 | 0.91 | RXRA (0.35) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL22966126 | 0.90 | RXRA (0.36) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL10072811 | 0.88 | RXRA (0.36) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL2755929 | 0.87 | AR (0.42) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL12148669 | 0.86 | RXRA (0.33) | RXRARXRBCTSSCTSKRXRG | |
| SCHEMBL2756419 | 0.86 | AR (0.39) | CTSSCTSKXDHAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088901-B2 | Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | CYP19A1, HSD17B2, AZI2 | RXRA 1835/4885RXRB 1798/4885CTSS 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.